Search - tctmd.com

Displaying 201 - 220 of 231

Sort: Relevancy | Date

News Conference News TCT 2014

Experts Look to Big Data to Identify New Therapeutic Targets for CVD

September 14, 2014

News Industry News

Boston Scientific Closes Acquisition Of Interventional Business Of Bayer AG

September 02, 2014

News Industry News

Amgen Announces Positive Top-Line Results From Phase 3 YUKAWA-2 Trial Of Evolocumab In Combination With Statins In Japanese Patients With High Cardiovascular Risk And High Cholesterol

August 28, 2014

News Industry News

Sanofi and Regeneron Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia

July 30, 2014

News Daily News

Dialysis Patients with Complex Coronary Disease Fare Better at 5 Years with CABG vs PCI

Caitlin E. Cox

June 24, 2014

News Daily News

CABG Mejor que PCI en Pacientes a Diálisis con Enfermedad Coronaria Compleja

Caitlin E. Cox

June 24, 2014

News Industry News

Boston Scientific Showcases Clinical and Economic Benefits of Endoscopy Products at Digestive Disease Week®

May 01, 2014

News Daily News

Poor Adherence to Dabigatran Common, Linked with Worse Clinical Outcomes

Yael L. Maxwell

April 17, 2014

News Daily News

Cardiac Cath via Radial Access Safe, Effective for Liver Transplant Patients

Jason Kahn

March 14, 2014

News Daily News

High-Risk Subgroups Derive Kidney Protection from Rosuvastatin

Caitlin E. Cox

October 11, 2013

News Conference News ESC 2013

ASSURE: RVX-208 Fails to Stall or Reverse CAD Progression vs. Placebo

September 02, 2013

News Conference News ESC 2013

TAO: Otamixaban Fails to Outshine Heparin Plus Eptifibatide in NSTE-ACS

Caitlin E. Cox

September 01, 2013

News Industry News

Positive Patient Outcomes at One Year With Edwards Sapien XT Transcatheter Valve

May 21, 2013

News Conference News ACC 2013

PARTNER: TAVR Still Safe, Effective at 3 Years, Stroke Risk Diminished

Yael L. Maxwell

March 11, 2013

News Conference News ACC 2013

PARTNER II Cohort B Demonstrates Safety, Efficacy of Lower Profile TAVR Device

L.A. McKeown

March 09, 2013

News Daily News

Patients Less Likely to Take Secondary Prevention Medications After CABG Than PCI

December 12, 2012

News Daily News

Apixaban Surpasses Warfarin At All Risk Levels in A-Fib Patients

Caitlin E. Cox

October 04, 2012

News Conference News ESC 2012

Niacin Holds No Surprise Side Effects But Efficacy Data Forthcoming

Caitlin E. Cox

August 26, 2012

News Daily News

Study Suggests Shortening Delay to Noncardiac Surgery After PCI

Yael L. Maxwell

August 17, 2012

News Daily News

No Safe Window for Triple Antithrombotic Therapy in High-Risk A-fib Patients

August 14, 2012

Advertisement

Experts Look to Big Data to Identify New Therapeutic Targets for CVD

Boston Scientific Closes Acquisition Of Interventional Business Of Bayer AG

Amgen Announces Positive Top-Line Results From Phase 3 YUKAWA-2 Trial Of Evolocumab In Combination With Statins In Japanese Patients With High Cardiovascular Risk And High Cholesterol

Sanofi and Regeneron Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia

Dialysis Patients with Complex Coronary Disease Fare Better at 5 Years with CABG vs PCI

CABG Mejor que PCI en Pacientes a Diálisis con Enfermedad Coronaria Compleja

Boston Scientific Showcases Clinical and Economic Benefits of Endoscopy Products at Digestive Disease Week®

Poor Adherence to Dabigatran Common, Linked with Worse Clinical Outcomes

Cardiac Cath via Radial Access Safe, Effective for Liver Transplant Patients

High-Risk Subgroups Derive Kidney Protection from Rosuvastatin

ASSURE: RVX-208 Fails to Stall or Reverse CAD Progression vs. Placebo

TAO: Otamixaban Fails to Outshine Heparin Plus Eptifibatide in NSTE-ACS

Positive Patient Outcomes at One Year With Edwards Sapien XT Transcatheter Valve

PARTNER: TAVR Still Safe, Effective at 3 Years, Stroke Risk Diminished

PARTNER II Cohort B Demonstrates Safety, Efficacy of Lower Profile TAVR Device

Patients Less Likely to Take Secondary Prevention Medications After CABG Than PCI

Apixaban Surpasses Warfarin At All Risk Levels in A-Fib Patients

Niacin Holds No Surprise Side Effects But Efficacy Data Forthcoming

Study Suggests Shortening Delay to Noncardiac Surgery After PCI

No Safe Window for Triple Antithrombotic Therapy in High-Risk A-fib Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content